China Tourette Syndrome Drug Market Research Report 2018

China Tourette Syndrome Drug Market Research Report 2017

1 Tourette Syndrome Drug Overview

1.1 Product Overview and Scope of Tourette Syndrome Drug

1.2 Classification of Tourette Syndrome Drug by Product Category

1.2.1 China Tourette Syndrome Drug Sales (K Pcs) Comparison by Type (2012-2022)

1.2.2 China Tourette Syndrome Drug Sales (K Pcs) Market Share by Type in 2016

1.2.3 AZD-5213

1.2.4 CPP-115

1.2.5 Dutetrabenazine ER

1.2.6 Ecopipam Hydrochloride

1.2.7 Others

1.3 China Tourette Syndrome Drug Market by Application/End Users

1.3.1 China Tourette Syndrome Drug Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)

1.3.2 Research Center

1.3.3 Hospital

1.3.4 Clinic

1.3.5 Others

1.4 China Tourette Syndrome Drug Market by Region

1.4.1 China Tourette Syndrome Drug Market Size (Million USD) Comparison by Region (2012-2022)

1.4.2 South China Tourette Syndrome Drug Status and Prospect (2012-2022)

1.4.3 East China Tourette Syndrome Drug Status and Prospect (2012-2022)

1.4.4 Southwest China Tourette Syndrome Drug Status and Prospect (2012-2022)

1.4.5 Northeast China Tourette Syndrome Drug Status and Prospect (2012-2022)

1.4.6 North China Tourette Syndrome Drug Status and Prospect (2012-2022)

1.4.7 Central China Tourette Syndrome Drug Status and Prospect (2012-2022)

1.5 China Market Size (Sales and Revenue) of Tourette Syndrome Drug (2012-2022)

1.5.1 China Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2022)

1.5.2 China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Tourette Syndrome Drug Market Competition by Players/Manufacturers

2.1 China Tourette Syndrome Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2 China Tourette Syndrome Drug Revenue and Share by Players/Manufacturers (2012-2017)

2.3 China Tourette Syndrome Drug Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)

2.4 China Tourette Syndrome Drug Market Competitive Situation and Trends

2.4.1 China Tourette Syndrome Drug Market Concentration Rate

2.4.2 China Tourette Syndrome Drug Market Share of Top 3 and Top 5 Players/Manufacturers

2.4.3 Mergers & Acquisitions, Expansion in China Market

2.5 China Players/Manufacturers Tourette Syndrome Drug Manufacturing Base Distribution, Sales Area, Product Types

3 China Tourette Syndrome Drug Sales and Revenue by Region (2012-2017)

3.1 China Tourette Syndrome Drug Sales (K Pcs) and Market Share by Region (2012-2017)

3.2 China Tourette Syndrome Drug Revenue (Million USD) and Market Share by Region (2012-2017)

3.3 China Tourette Syndrome Drug Price (USD/Pcs) by Regions (2012-2017)

4 China Tourette Syndrome Drug Sales and Revenue by Type/ Product Category (2012-2017)

4.1 China Tourette Syndrome Drug Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)

4.2 China Tourette Syndrome Drug Revenue (Million USD) and Market Share by Type (2012-2017)

4.3 China Tourette Syndrome Drug Price (USD/Pcs) by Type (2012-2017)

4.4 China Tourette Syndrome Drug Sales Growth Rate (%) by Type (2012-2017)

5 China Tourette Syndrome Drug Sales by Application (2012-2017)

5.1 China Tourette Syndrome Drug Sales (K Pcs) and Market Share by Application (2012-2017)

5.2 China Tourette Syndrome Drug Sales Growth Rate (%) by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 China Tourette Syndrome Drug Players/Suppliers Profiles and Sales Data

6.1 Abide Therapeutics Inc

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Tourette Syndrome Drug Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.1.4 Main Business/Business Overview

6.2 Catalyst Pharmaceuticals Inc

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Tourette Syndrome Drug Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.2.4 Main Business/Business Overview

6.3 Neurocrine Biosciences Inc

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Tourette Syndrome Drug Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.3.4 Main Business/Business Overview

6.4 Psyadon Pharmaceuticals Inc

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Tourette Syndrome Drug Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.4.4 Main Business/Business Overview

6.5 Reviva Pharmaceuticals Inc

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Tourette Syndrome Drug Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.5.4 Main Business/Business Overview

6.6 Synchroneuron Inc

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Tourette Syndrome Drug Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.6.4 Main Business/Business Overview

6.7 Teva Pharmaceutical Industries Ltd

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Tourette Syndrome Drug Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.7.4 Main Business/Business Overview

6.8 Therapix Biosciences Ltd

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Tourette Syndrome Drug Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.8.4 Main Business/Business Overview

7 Tourette Syndrome Drug Manufacturing Cost Analysis

7.1 Tourette Syndrome Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Tourette Syndrome Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Tourette Syndrome Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Tourette Syndrome Drug Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China Tourette Syndrome Drug Market Size (Sales and Revenue) Forecast (2017-2022)

11.1 China Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)

11.2 China Tourette Syndrome Drug Sales (K Pcs) Forecast by Type (2017-2022)

11.3 China Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)

11.4 China Tourette Syndrome Drug Sales (K Pcs) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Figure Global and China Market Size (Million USD) Comparison (2012-2022)

Table Tourette Syndrome Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type

Table Tourette Syndrome Drug Sales (K Pcs) by Application (2016-2022)

Figure Product Picture of Tourette Syndrome Drug

Table China Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)

Figure China Tourette Syndrome Drug Sales Volume Market Share by Types in 2016

Figure AZD-5213 Product Picture

Figure CPP-115 Product Picture

Figure Dutetrabenazine ER Product Picture

Figure Ecopipam Hydrochloride Product Picture

Figure Others Product Picture

Figure China Tourette Syndrome Drug Sales (K Pcs) Comparison by Application (2012-2022)

Figure China Sales Market Share (%) of Tourette Syndrome Drug by Application in 2016

Figure Research Center Examples

Table Key Downstream Customer in Research Center

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Others Examples

Table Key Downstream Customer in Others

Figure South China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure East China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Northeast China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure North China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Central China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2022)

Figure China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)

Table China Tourette Syndrome Drug Sales of Key Players/Manufacturers (2012-2017)

Table China Tourette Syndrome Drug Sales Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Tourette Syndrome Drug Sales Share (%) by Players/Manufacturers

Figure 2017 China Tourette Syndrome Drug Sales Share (%) by Players/Manufacturers

Table China Tourette Syndrome Drug Revenue by Players/Manufacturers (2012-2017)

Table China Tourette Syndrome Drug Revenue Market Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Tourette Syndrome Drug Revenue Market Share (%) by Players/Manufacturers

Figure 2017 China Tourette Syndrome Drug Revenue Market Share (%) by Players/Manufacturers

Table China Market Tourette Syndrome Drug Average Price of Key Players/Manufacturers (2012-2017)

Figure China Market Tourette Syndrome Drug Average Price of Key Players/Manufacturers in 2016

Figure China Tourette Syndrome Drug Market Share of Top 3 Players/Manufacturers

Figure China Tourette Syndrome Drug Market Share of Top 5 Players/Manufacturers

Table China Players/Manufacturers Tourette Syndrome Drug Manufacturing Base Distribution and Sales Area

Table China Players/Manufacturers Tourette Syndrome Drug Product Category

Table China Tourette Syndrome Drug Sales (K Pcs) by Regions (2012-2017)

Table China Tourette Syndrome Drug Sales Share (%) by Regions (2012-2017)

Figure China Tourette Syndrome Drug Sales Share (%) by Regions (2012-2017)

Figure China Tourette Syndrome Drug Sales Market Share (%) by Regions in 2016

Table China Tourette Syndrome Drug Revenue (Million USD) and Market Share by Regions (2012-2017)

Table China Tourette Syndrome Drug Revenue Market Share (%) by Regions (2012-2017)

Figure China Tourette Syndrome Drug Revenue Market Share (%) by Regions (2012-2017)

Figure China Tourette Syndrome Drug Revenue Market Share (%) by Regions in 2016

Table China Tourette Syndrome Drug Price (USD/Pcs) by Regions (2012-2017)

Table China Tourette Syndrome Drug Sales (K Pcs) by Type (2012-2017)

Table China Tourette Syndrome Drug Sales Share (%) by Type (2012-2017)

Figure China Tourette Syndrome Drug Sales Share (%) by Type (2012-2017)

Figure China Tourette Syndrome Drug Sales Market Share (%) by Type in 2016

Table China Tourette Syndrome Drug Revenue (Million USD) and Market Share by Type (2012-2017)

Table China Tourette Syndrome Drug Revenue Market Share (%) by Type (2012-2017)

Figure Revenue Market Share of Tourette Syndrome Drug by Type (2012-2017)

Figure Revenue Market Share of Tourette Syndrome Drug by Type in 2016

Table China Tourette Syndrome Drug Price (USD/Pcs) by Types (2012-2017)

Figure China Tourette Syndrome Drug Sales Growth Rate (%) by Type (2012-2017)

Table China Tourette Syndrome Drug Sales (K Pcs) by Applications (2012-2017)

Table China Tourette Syndrome Drug Sales Market Share (%) by Applications (2012-2017)

Figure China Tourette Syndrome Drug Sales Market Share (%) by Application (2012-2017)

Figure China Tourette Syndrome Drug Sales Market Share (%) by Application in 2016

Table China Tourette Syndrome Drug Sales Growth Rate (%) by Application (2012-2017)

Figure China Tourette Syndrome Drug Sales Growth Rate (%) by Application (2012-2017)

Table Abide Therapeutics Inc Tourette Syndrome Drug Basic Information List

Table Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales Market Share (%) in China (2012-2017)

Figure Abide Therapeutics Inc Tourette Syndrome Drug Revenue Market Share (%) in China (2012-2017)

Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Basic Information List

Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Market Share (%) in China (2012-2017)

Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (%) in China (2012-2017)

Table Neurocrine Biosciences Inc Tourette Syndrome Drug Basic Information List

Table Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Market Share (%) in China (2012-2017)

Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Revenue Market Share (%) in China (2012-2017)

Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Basic Information List

Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Market Share (%) in China (2012-2017)

Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (%) in China (2012-2017)

Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Basic Information List

Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Market Share (%) in China (2012-2017)

Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (%) in China (2012-2017)

Table Synchroneuron Inc Tourette Syndrome Drug Basic Information List

Table Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Synchroneuron Inc Tourette Syndrome Drug Sales Market Share (%) in China (2012-2017)

Figure Synchroneuron Inc Tourette Syndrome Drug Revenue Market Share (%) in China (2012-2017)

Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Basic Information List

Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Market Share (%) in China (2012-2017)

Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Revenue Market Share (%) in China (2012-2017)

Table Therapix Biosciences Ltd Tourette Syndrome Drug Basic Information List

Table Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales Market Share (%) in China (2012-2017)

Figure Therapix Biosciences Ltd Tourette Syndrome Drug Revenue Market Share (%) in China (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Tourette Syndrome Drug

Figure Manufacturing Process Analysis of Tourette Syndrome Drug

Figure Tourette Syndrome Drug Industrial Chain Analysis

Table Raw Materials Sources of Tourette Syndrome Drug Major Players/Manufacturers in 2016

Table Major Buyers of Tourette Syndrome Drug

Table Distributors/Traders List

Figure China Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)

Figure China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Tourette Syndrome Drug Price (USD/Pcs) Trend Forecast (2017-2022)

Table China Tourette Syndrome Drug Sales (K Pcs) Forecast by Type (2017-2022)

Figure China Tourette Syndrome Drug Sales (K Pcs) Forecast by Type (2017-2022)

Figure China Tourette Syndrome Drug Sales Volume Market Share Forecast by Type in 2022

Table China Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)

Figure China Tourette Syndrome Drug Sales Volume Market Share Forecast by Application (2017-2022)

Figure China Tourette Syndrome Drug Sales Volume Market Share Forecast by Application in 2022

Table China Tourette Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)

Table China Tourette Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)

Figure China Tourette Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)

Figure China Tourette Syndrome Drug Sales Volume Share Forecast by Regions in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources